Sensei Biotherapeutics Says It Completed SNS-101 Monotherapy Dose Escalation Through 15 Mg/Kg With No Dose Limiting Toxicities; Highlights Strong Balance Sheet With Cash Runway Extended Into Q4 Of 2025
Author: Benzinga Newsdesk | January 04, 2024 08:43am